Plain-English translation of NCT07688551 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether transcranial direct current stimulation (tDCS)—a noninvasive technique that uses small electrical currents to stimulate brain activity—works better when combined with speech therapy to help people with Broca's aphasia recover their language abilities. Broca's aphasia is a condition that affects speech and language after a stroke, making it hard to find words and express thoughts. The trial will first figure out the best dose of stimulation, then compare this treatment against speech therapy alone to see if the combination helps people name objects and communicate more effectively.
Many people with Broca's aphasia struggle to recover their language abilities with speech therapy alone. This trial exists to find out whether adding brain stimulation to speech therapy can boost recovery and help people regain their ability to speak and understand language better.
You likely qualify if…
You likely don't qualify if…
You would receive speech therapy combined with noninvasive brain stimulation applied through small electrode pads on your scalp. The study first determines the best stimulation dose, and then tests whether this combined approach works better than speech therapy alone. Visits would involve receiving the stimulation for about 20 minutes while receiving speech therapy, and your progress with naming and language skills would be tracked over time.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States